Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum -- Ignore unavailable to you. Want to Upgrade?

To: sense who wrote (154891)	3/20/2020 10:26:11 PM
From: Dr. Voodoo	Read Replies (2) \| Respond to of 218430

Summary from Player 1: MGH, MD Ph.D. Plaquenil: only good for cytokine storm-- not as prophylactic. won't stop new infections, TI is an issue. etc. Quinine built up in system? Maybe but not bullet. won't stop you from getting it, won't reduce viral burden Current antivirals that might work? All in short supply. Nobody jumping in pool for clinical testing without something solid. Can't jump in pool without being found out. nobody footing that bill on craphshoot. Lots of goings on. It will be a while. Do not listen to orangemanbad. turn off the nooz Player 2: PhD. Pharma, and BioSpook. Focus on testing, environmental persistence Biology R&D but mundane R&D developing and scaling testing etc. CDC has their problems,,, overabundance of CYA Don't listen to orangemanbad, turn off the stupid nooz. NY is running up the score because testing taking off. Player 3: PhD. Pharma dev. Zinc ECGC, Quercitin, stay the away from sick people.